Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Prothena reported $70.52M in Operating Expenses for its fiscal quarter ending in June of 2023.

Operating Expenses Change Date
Acadia Pharmaceuticals USD 269.47M 107.28M Sep/2023
Agios Pharmaceuticals USD 108.3M 7.88M Sep/2023
ALKERMES USD 337.09M 41.11M Sep/2023
Alnylam Pharmaceuticals USD 536.66M 11.92M Sep/2023
Amgen USD 4.81B 511M Sep/2023
Biogen USD 2.37B 502.4M Sep/2023
BioMarin Pharmaceutical USD 555.67M 19.26M Sep/2023
Bluebird Bio USD 97.12M 4.93M Sep/2023
Exelixis USD 489.5M 97.5M Sep/2023
Immunic USD 23.57M 1.45M Sep/2023
Incyte USD 704.32M 56.51M Sep/2023
Intra Cellular Therapies USD 155.89M 2.08M Sep/2023
Ionis Pharmaceuticals USD 289.57M 22.27M Sep/2023
Nektar Therapeutics USD 69.01M 2.09M Sep/2023
Neurocrine Biosciences USD 357.6M 21.5M Sep/2023
Regeneron Pharmaceuticals USD 2.25B 110.1M Sep/2023
Ultragenyx Pharmaceutical USD 243.15M 13.12M Sep/2023
Vertex Pharmaceuticals USD 1.45B 21.4M Sep/2023
Xoma USD 6.62M 998K Sep/2023